Cytokinetics | CYTK - Ebitda



金融业
股票价格
USD
资产
USD 1.92B
现金及等价物
USD 255.27M
销售成本
USD 5.59M
流动资产
USD 1.21B
流动负债
USD 181.43M
债务
USD 1.29B
EBIT
USD -179.17M
EBITDA
USD -169.32M
员工
498
EPS每股收益
USD -1.5
股本和储备
USD -173.49M
销售毛利
USD 23.03M
债务利息支出
USD 34.83M
利息收入
USD 11.02M
贷款资金
USD 248.2M
市值
USD 7.38B
净收入
USD -198.76M
营业费用
USD 207.8M
营业利润
USD -179.17M
普通股股本
USD 124.43M
税前利润
USD -206.03M
销售收入
USD 28.6M
销售和管理费用
USD 104.4M
股票
USD 380K
贸易债权人
USD 20.51M
应收帐款人
USD 6.83M


Ebitda 更改 日
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Amgen USD 3.86B 1.28B 2026-03
Arca Biopharma USD -25.07M 5.23M 2025-03
Bayer EUR 2.14B 2.31B 2026-06
Biogen USD 649.7M 76.5M 2026-03
Brainstorm Cell Therapeutics USD -3.04M 99K 2025-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Capricor Therapeutics USD -27.23M 2.66M 2025-06
Cytokinetics USD -169.32M 19.48M 2026-03
Eisai JPY 34.15B 34.48B 2026-06
Eli Lilly USD 10.29B 1.86B 2026-03
Exelixis USD 255.4M 2.89M 2026-06
Geron USD 3.83M 25.12M 2026-03
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Ligand Pharmaceuticals USD -14.3M 81.08M 2026-03
Merck USD -1.54B 7.84B 2026-03
Novartis USD 6.48B 1.19B 2026-06
Pfizer USD 6.01B 18M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06